European Journal of Heart Failure

The European Journal of Heart Failure (EJHF) is a monthly peer-reviewed journal published by Oxford University Press as the official journal of the Heart Failure Association of the European Society of Cardiology, founded in 1999 and devoted to basic, clinical and population research on heart failure, with a 2025 Journal Impact Factor of 10.3《欧洲心力衰竭杂志》（European Journal of Heart Failure，EJHF）是（Oxford University Press）出版的月刊同行评审期刊，为欧洲心脏病学会（ESC）心力衰竭协会（HFA）的官方期刊，1999 年创刊，发表心力衰竭领域的基础、临床与人口科学研究，2025 年影响因子为 10.3。

Scope

• The journal is dedicated to the advancement of knowledge in the field of heart failure, including the understanding, prevention, investigation and treatment of the syndrome该刊致力于推进心力衰竭领域的知识进步，涵盖对该综合征的认识、预防、研究与治疗。
• Its subject range spans molecular and cellular biology, pathology, physiology, electrophysiology and pharmacology, as well as the clinical, social and population sciences that together make up the discipline of heart failure其学科范围涵盖分子与细胞生物学、病理学、生理学、电生理学与药理学，以及共同构成心力衰竭学科的临床、社会与人口科学。
• The journal welcomes submissions across basic, clinical and population sciences, and original contributions on nursing, care of the elderly, primary care, health economics and other specialist fields related to heart failure该刊欢迎基础科学、临床科学与人口科学方向的投稿，亦欢迎护理、老年照护、初级保健、卫生经济学及其他心力衰竭相关专门领域的原创成果。
• Besides original research it publishes reviews, editorials, guidelines, position papers and guideline updates, with the primary focus on original work and up-to-date analyses from clinical trials除原创研究外，该刊还发表综述、社论、指南、立场文件与指南更新，重点放在原创工作与临床试验的最新分析上。
• Its readership includes cardiologists, heart failure specialists and internists, and extends to intensive care physicians, nephrologists and pulmonologists because of the high burden of comorbidities in heart failure patients读者群体包括心脏病学家、心力衰竭专家与内科医师，并因心力衰竭患者共病负担高而延伸至重症监护医师、肾脏科医师与呼吸科医师。
• It is a subscription journal with optional open access, published online and in print, with twelve issues per year该刊为订阅期刊并可选开放获取，在线与印刷版并行出版，每年出版 12 期。
• It is abstracted and indexed in the Science Citation Index Expanded, Scopus, MEDLINE and other major databases, and in the 2025 Journal Citation Reports it ranks in the first quartile of the Cardiac and Cardiovascular Systems category该刊被（SCIE）、（Scopus）、（MEDLINE）等主要数据库收录，在 2025 年期刊引证报告中位列（CARDIAC & CARDIOVASCULAR SYSTEMS）类目第一分区。

History

• The first issue appeared in 1999 under the founding editor John G. F. Cleland of Hull in the United Kingdom, supported by the European Society of Cardiology and its Working Group on Heart Failure, later renamed the Heart Failure Association该刊于 1999 年出版首期，创刊主编为英国赫尔大学的（John G. F. Cleland），由欧洲心脏病学会及其心力衰竭工作组（后更名心力衰竭协会）支持创办。
• Four issues were published in 1999, rising to six per year from 2001, eight in 2006, eleven in 2007 and a stable twelve per year from 2008 onwards1999 年出版 4 期，2001 年起增至每年 6 期，2006 年为 8 期，2007 年为 11 期，2008 年起固定为每年 12 期。
• The impact factor grew from 1.2 in 2001 and 2.9 in 2004 to 3.7 in 2009, and the journal became fully electronic with online submission and peer review in 2005影响因子由 2001 年的 1.2、2004 年的 2.9 增长至 2009 年的 3.7，该刊并于 2005 年实现全面电子化投稿与同行评审。
• Editors-in-chief have included Karl Swedberg of Gothenburg from 2005, Dirk J. van Veldhuisen of Groningen from 2010 and Marco Metra of Brescia from 2015, each moving the editorial office with them历任主编包括 2005 年起任主编的哥德堡的（Karl Swedberg）、2010 年起任主编的格罗宁根的（Dirk J. van Veldhuisen）与 2015 年起任主编的布雷西亚的（Marco Metra），编辑部随之先后迁址。
• Michael Bohm, director of internal medicine, cardiology, angiology and intensive care medicine at the University of the Saarland in Homburg, Germany, was announced as the next editor-in-chief in late 2024 and took office in 2025德国洪堡萨尔大学内科学、心脏病学、血管病学与重症医学主任（Michael Bohm）于 2024 年底获宣布接任主编，并于 2025 年上任。
• The journal was published by Elsevier in its first decade, by Wiley-Blackwell from 2009, and moved to Oxford University Press in January 2026, when all ESC journals were consolidated under a single publisher该刊创刊后的第一个十年由（Elsevier）出版，2009 年起改由（Wiley-Blackwell）出版，2026 年 1 月起转由（Oxford University Press）出版，实现（ESC）全部期刊归口同一出版方。
• Its impact factor reached 15.534 in 2021 and 17.349 in 2022, and was recorded at 10.8 for 2024 and 10.3 for 2025其影响因子 2021 年为 15.534，2022 年为 17.349，2024 年为 10.8，2025 年为 10.3。

Editors

• Michael Bohm of Saarland University Hospital in Germany is the editor-in-chief, a clinical and experimental pharmacologist whose research covers cardiovascular interventions including renal denervation德国萨尔大学医院（Saarland University Hospital）的（Michael Bohm）任主编，他是临床与实验药理学家，研究领域涵盖肾脏去神经消融等心血管介入技术。
• Seven deputy editors-in-chief support him, among them Antoni Bayes-Genis in Spain, Wilfried Mullens in Belgium, Ovidiu Chioncel in Romania, Mark Petrie in the United Kingdom, Stefanie Dimmeler in Germany, Gianluigi Savarese in Sweden and Felix Mahfoud in Switzerland7 位副主编协助其工作，包括西班牙的（Antoni Bayes-Genis）、比利时的（Wilfried Mullens）、罗马尼亚的（Ovidiu Chioncel）、英国的（Mark Petrie）、德国的（Stefanie Dimmeler）、瑞典的（Gianluigi Savarese）与瑞士的（Felix Mahfoud）。
• A board of senior consulting editors includes former editors-in-chief John Cleland, Karl Swedberg, Dirk van Veldhuisen and Marco Metra, together with John McMurray, Piotr Ponikowski, Deepak Bhatt and Marc Pfeffer资深咨询编辑包括前主编（John Cleland）、（Karl Swedberg）、（Dirk van Veldhuisen）与（Marco Metra），以及（John McMurray）、（Piotr Ponikowski）、（Deepak Bhatt）与（Marc Pfeffer）。
• Fifty associate editors, a large international editorial board, a young faculty editorial board and ten regional consulting editors spanning five continents handle manuscripts, and social media editors coordinate online dissemination50 位副主编、规模庞大的国际编辑委员会、青年教员编辑委员会以及遍布五大洲的 10 位区域咨询编辑共同处理稿件，社媒编辑负责线上传播。
• Manuscripts are submitted through the Editorial Manager online system, and the journal is a member of the Committee on Publication Ethics and follows the recommendations of the International Committee of Medical Journal Editors稿件通过（Editorial Manager）在线系统投递，该刊为国际出版伦理委员会（COPE）成员，并遵循国际医学期刊编辑委员会（ICMJE）的建议。
• The editor-in-chief has built a local editorial committee in Homburg and states that the journal aims to remain the leading heart failure journal worldwide by providing scientific innovation swiftly to readers主编在洪堡组建了本地编辑委员会，并表示该刊将以最快速度向读者提供科学创新，保持全球心力衰竭领域领先期刊的地位。
• A sister open access journal, ESC Heart Failure, is published by the same association under editor-in-chief Piotr Ponikowski同一协会还出版开放获取姊妹刊（ESC Heart Failure），由（Piotr Ponikowski）任主编。